Nonsteroidal anti-inflammatory drug use and acute myocardial infarction

Archives of Internal Medicine

Volumn 162, Issue 10, 2002, Pages 1099-1104

  Solomon, Daniel H ^a   Glynn, Robert J ^a   Levin, Raisa ^a   Avorn, Jerry ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; ETODOLAC; FENOPROFEN; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPRAZINE; PIROXICAM; SULINDAC; TOLMETIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG EFFECT; DRUG EXPOSURE; DRUG USE; ELECTROCARDIOGRAPHY; ENZYME INHIBITION; FEMALE; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRESCRIPTION; PRIORITY JOURNAL; SHEAR STRESS; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0037182013     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.10.1099     Document Type: Article

References (28)

1. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
2. Inhibition of prostaglandin synthesis as a mechanism of action for aspirinlike drugs
3. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis
4. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls
5. Final report on the aspirin component of the ongoing Physicians' Health Study
6. A case-control study of regular aspirin use and coronary deaths
7. Differential effects of aspirin and nonaspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women
8. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs
9. Coding of acute myocardial infarction
10. The accuracy of Medicare's hospital claims data
11. Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database
12. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs
13. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
14. A survey of aspirin use, non-prescription NSAID use, and cigarette smoking among users and non-users of prescription NSAIDs
15. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays
16. Relative potency of nonsteroid anti-inflammatory drugs as inhibitors of cyclooxygenase-1 or cyclooxygenase-2
17. Atherosclerosis
18. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial
19. Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors: A report of four cases
20. Risk of cardiovascular events associated with selective COX-2 inhibitors
21. Eicosanoids in regulation of arterial smooth muscle cell phenotype, proliferative capacity, and cholesterol metabolism
22. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli